Last $14.46 USD
Change Today -0.06 / -0.41%
Volume 32.8K
OSIR On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 12:05 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Philip R. Jacoby Jr.

Chief Financial Officer, Treasurer and Corporate Secretary, Osiris Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

61$307,333
As of Fiscal Year 2013

Background*

Mr. Philip R. Jacoby, Jr. has been Chief Financial Officer, Company Secretary and Treasurer of Osiris Therapeutics, Inc. since July 2009, November 2007 and May 2010 respectively. Mr. Jacoby is responsible for all financial and SEC reporting matters and is deeply involved in contract negotiations and budgets. He served as Chief Accounting Officer of Osiris Therapeutics, Inc. and also served as its Vice President of Finance since July 2008. He served as an Assistant Corporate ...

Read Full Background

Corporate Headquarters*

7015 Albert Einstein Drive
Columbia, Maryland 21046

United States

Phone: 443-545-1800
Fax: 443-545-1701

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Bachelor's Degree
University of Maryland

Other Affiliations*

Annual Compensation*

Salary$207,333
Bonus$20,000
Total Annual Compensation$227,333

Stock Options*

Exercised Options18,372
Exercised Options Value$175,448
Exercisable Options43,253
Unexercisable Options51,875
Total Value of Options$175,448
Total Number of Options113,500

Total Compensation*

Total Annual Cash Compensation$227,333
Total Short Term Compensation$227,333
Total Calculated Compensation$307,333
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSIR:US $14.46 USD -0.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$745.3K
Robin L. Smith M.D., MBA,RoExecutive Chairman and Chief Executive Officer
Neostem, Inc.
$945.0K
Thomas Axelsson M.Sc.Chief Executive Officer
Vitrolife AB (publ)
kr3.7M
Paul K. Wotton Ph.D.Chief Executive Officer and President
Advanced Cell Technology Inc.
--
Keith Murphy Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee
Organovo Holdings, Inc.
$362.9K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OSIRIS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.